Adagrasib Recruiting Phase 2 Trials for Malignant Neoplasm of Lung / Metastatic Cancer / Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05853575Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)